Young & Partners Pharmaceutical Executive Summit 2024: The Impact of Artificial Intelligence on the Creation of Medicines (Pharmaceutical Executive)Jonathan Choi2024-11-06T21:10:32+00:00October 24th, 2024|Featured, Our Publications|
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading? (Pharmaceutical Executive)Jonathan Choi2024-11-06T21:10:53+00:00October 23rd, 2024|Featured, Our Publications|
Industry Restructuring & Inorganic Growth Through an Era of Chronic Oversupply (World Chemical Forum Speech September 10, 2024)Jonathan Choi2024-10-14T18:41:13+00:00September 10th, 2024|Featured, Our Publications|
Chemical Debt Financing Rebounds (ICIS Chemical Business September 6 – September 12, 2024)Jonathan Choi2024-10-15T15:22:50+00:00September 6th, 2024|Featured, Our Publications|
Chemical M&A Retreats Further (ICIS Chemical Business August 31 – September 5, 2024)Jonathan Choi2024-09-17T14:15:04+00:00September 5th, 2024|Featured, Our Publications|
Chemical Financing Activity Mixed (ICIS Chemical Business May 31 – June 6, 2024)Jonathan Choi2024-06-20T16:34:06+00:00May 31st, 2024|Featured, Our Publications|
Chemical M&A Market Retreats (ICIS Chemical Business May 17 – May 23, 2024)Jonathan Choi2024-05-22T20:35:28+00:00May 17th, 2024|Featured, Our Publications|
Young & Partners Chemical Financing: Reflections on 2023 and Outlook (March 2024)Jonathan Choi2024-05-22T20:36:59+00:00March 26th, 2024|Featured, Our Publications|
Biopharma Industry Business Review and Outlook (Pharmaceutical Executive, March 2024)Jonathan Choi2024-03-20T17:34:33+00:00March 20th, 2024|Featured, Our Publications|
Biopharma Market Review and Outlook (Pharmaceutical Executive, October 2023)Jonathan Choi2023-10-16T14:00:23+00:00October 16th, 2023|Featured, Our Publications|
